
    
      A Phase 1, Two Stage, Single Dose, Single-Blind, Placebo Controlled, Dose Escalation,
      Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and
      Subjects With Well-Controlled Celiac Disease
    
  